TY -的A2 Bassukas Ioannis d . AU - Ishibashi Masafumi盟——Shiiyama Rie PY - 2020 DA - 2020/02/14 TI -的牛皮癣寻常的对待Brodalumab与终末期肾病血液透析患者由于糖尿病肾病SP - 3863152六世- 2020 AB -牛皮癣寻常的不是在血透患者中常见。然而，由于担心并发症，这些病人对银屑病的治疗有限。我们报告的情况下银屑病患者终末期肾病血液透析，安全治疗brodalumab。一位60岁男性，有20年顽固性严重牛皮癣病史。40年前患糖尿病，两个月前肾功能不全进展，开始血液透析。他用brodalumab治疗，皮肤损伤明显改善。在开始使用brodalumab四个月后，他开始出现慢性咳嗽。CT显示双肺弥漫毛玻璃影及胸腔积液。经支气管肺活检未见提示间质性肺炎。在支气管肺泡灌洗液中未发现分枝杆菌和真菌。 The T-SPOT.TB test was negative. It was considered to be a symptom of overflow due to excessive fluid volume based on insufficient dietary management. Brodalumab was continued, and respiratory symptoms improved with proper weight setting and adequate dietary control. No recurrence of rash has been seen 12 months after the initiation of brodalumab. There were no serious adverse events. SN - 2090-6463 UR - https://doi.org/10.1155/2020/3863152 DO - 10.1155/2020/3863152 JF - Case Reports in Dermatological Medicine PB - Hindawi KW - ER -